Is the increase in LDL cholesterol induced by selective serotonin reuptake inhibitor therapy a blessing in disguise?

Medical Hypotheses

Volumn 74, Issue 5, 2010, Pages 955-956

  Goldstein, Mark R ^a   Mascitelli, Luca ^b   Pezzetta, Francesca ^c  

^a Fountain Medical Court ^*  (United States)

^b Comando Brigata Alpina Julia ^*  (Italy)

^c Ospedale Civile di Tolmezzo   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SIMVASTATIN;

BEHAVIOR DISORDER; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; DEPRESSION; DRUG ACTIVITY; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; HOMICIDE; HUMAN; LETTER; MOOD DISORDER; MORTALITY; SIDE EFFECT; SUICIDE;

AFFECT; ANTICHOLESTEREMIC AGENTS; CHOLESTEROL, LDL; DEPRESSION; HUMANS; PAROXETINE; SEROTONIN UPTAKE INHIBITORS;

EID: 77950955724     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2009.11.041     Document Type: Letter

References (9)

1. Raeder M.B., Bjelland I., Vollset S.E., Steen V.M. Obesity, dyslipidemia, and diabetes with selective serotonin reuptake inhibitors: the Hordaland health study. J Clin Psychiatry 2006, 67:1974-1982.
2. Le Melledo J.M., Mailo K., Lara N., et al. Paroxetine-induced increase in LDL cholesterol levels. J Psychopharmacol 2009, 23:826-830.
3. Troisi A. Cholesterol in coronary heart disease and psychiatric disorders: same or opposite effects on morbidity risk?. Neurosci Biobehav Rev 2009, 33:125-132.
4. Boscarino J.A., Erlich P.M., Hoffman S.N. Low serum cholesterol and external cause mortality: potential implications for research and surveillance. J Psychiatr Res 2009, 43:848-854.
5. Troisi A., Moles A., Panepuccia L., Lo Russo D., Palla G., Scucchi S. Serum cholesterol levels and mood symptoms in the postpartum period. Psychiatry Res 2002, 109:213-219.
6. Morales K., Wittink M., Datto C., et al. Simvastatin causes changes in affective processes in elderly volunteers. J Am Geriatr Soc 2006, 54:70-76.
7. Locatelli S., Lütjohann D., Schmidt H.H., Otto C., Beisiegel U., von Bergmann K. Reduction of plasma 24S-hydroxycholesterol (cerebrosterol) levels using high dosage simvastatin in patients with hypercholesterolemia: evidence that simvastatin affects cholesterol metabolism in the human brain. Arch Neurol 2002, 59:213-216.
8. Arnett D.K., Jacobs D.R., Luepker R.V., Blackburn H., Armstrong C., Claas S.A. Twenty-year trends in serum cholesterol, hypercholesterolemia, and cholesterol medication use: the Minnesota Heart Survey, 1980-1982 to 2000-2002. Circulation 2005, 112:3384-3391.
9. Glassman A.H., Bigger J.T. Antidepressants in coronary heart disease: SSRIs reduce depression, but do they save lives?. JAMA 2007, 297:411-412.